Morphea
☆ AI Dermatology — Free Service
I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
O le manu'a o le Morphea e masani ona aliali mai i se paʻu lanu atrophic.
relevance score : -100.0%
ReferencesScleroderma ose fa'ama'i e seasea ona a'afai ai a'ano feso'ota'i, fa'aalia e pei o le paʻu ma'a'a ma o nisi taimi e a'afai ai isi vaega o le tino. E lua ituaiga autu: systemic sclerosis, e aofia ai le mamā'aina o le paʻu ma totoga i totonu, ma le localized scleroderma, e taʻua foi o le morphea, lea e masani ona faʻatapulaʻa i le paʻu ma aano o lo'o i lalo, fa'atasi ai ma se faiga faʻapitoa ma faʻatapulaʻaina. E ui lava e le masani ai le scleroderma i le lotoifale ma e le o manino lona mafua'aga, o suʻesuʻega talu ai nei e faʻaalia ai e mafai foi ona aʻafia ai totoga i totonu ma taʻitaʻia ai faʻafitauli eseese o le soifua maloloina. O togafitiga vave e taua tele e puipuia ai faʻalavelave, pe a tuʻuina atu le ogaoga o le localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea, e ta'ua fo'i o le localized scleroderma, ose fa'ama'i e seasea ona a'afia ai aano feso'ota'i. E mafai ona fa'aalia i ni auala 'ese'ese, ma e le masani ai, pe 0.4-2.7 mataupu i le 100,000 tagata i tausaga ta'itasi. Morphea e masani ona vaaia i tamaiti i le va o le 2 ma le 14 tausaga, ma e masani ona a'afia ai teine na'i lo tama.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea o se ma'i e le masani ona maua. Ona o le tuufaatasiga o le ata, atonu na faaseseina e le algorithm mo Morphea.